SNIPR Biome – CRISPR and gene therapy of the microbiome
SNIPRBiome's targeted microbiome engineering will revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota.
SNIPR Biome develops targeted delivery methods containing a proprietary CRISPR platform. Such particles hold the potential to modulate and control the microbiome as well as eradicate potentially life-threatening, multi-resistant bacteria without harming the natural flora, providing a safe way to treat such infections.
Industry
Therapeutics
